SCHEIBLER LUKAS 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 17, 2023
Insider Transaction Report
Form 4
SCHEIBLER LUKAS
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-01-12$52.66/sh+35,472$1,867,956→ 35,472 totalExercise: $52.66Exp: 2033-01-11→ Common Stock (35,472 underlying) - Award
Common Stock
2023-01-12+22,580→ 63,707 total
Footnotes (3)
- [F1]This represents a Restricted Stock Award granted 01/12/23 that vest annually from grant date over a four year period subject to continued service.
- [F2]This includes 769 shares from 04/29/2022 ESPP purchase.
- [F3]This represents a stock option award granted 01/12/2023 that vest over a four year period. 25% vest one year from grant date and the remaining 75% vest monthly thereafter subject to continued service.